HIF1A and breast cancer: Resveratrol analogs further suppress epigenetic-triggered hypoxia-inducible factor 1-alpha (HIF-1α) and VEGF in BC, thereby sensitizing the effect of radiotherapy effectively through the modulation of the hypoxic state and blood flow under hypoxia conditions, leading to the inhibition of angiogenesis [173].